← Back to patent-cliff list
CAS 460-00-4
1-bromo-4-fluorobenzene
Codes: CANA-010, ESCI-002
Application context (from source-drug indications)
End-stage renal diseaseCanagliflozin/Metformin HydrochlorideCardiac and vascular disordersCanagliflozin/Metformin HydrochlorideAbdominal aortic aneurysmCanagliflozin/Metformin HydrochlorideType 2 diabetesCanagliflozin/Metformin HydrochlorideType 2 diabetesCanagliflozin HemihydrateDiabetic nephropathyCanagliflozin HemihydrateCoronary artery lesionCanagliflozin HemihydrateDiabetesCanagliflozin HemihydrateHeart failureCanagliflozin HemihydrateEnd-stage renal diseaseCanagliflozin Hemihydrate社交恐惧症Escitalopram OxalateMajor depressive disorderEscitalopram OxalatePanic disorderEscitalopram OxalateDepressionEscitalopram OxalateAnxiety disorderEscitalopram OxalateIrritable bowel syndromeEscitalopram Oxalate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Canagliflozin/Metformin Hydrochloride | Tier B — Position early | 2029 |
| Canagliflozin Hemihydrate | Tier C — Watch / trade | - |
| Escitalopram Oxalate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(4-fluorophenyl)thiophene→2-bromothiophene→1-bromo-4-fluorobenzene→5-iodo-2-methylbenzoyl chloride→2-(4-fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene→(2R,3R,4S,5R)-2-(acetoxymethyl)-6-oxotetrahydro-2H-pyran-3,4,5-triyl triacetate→(3R,4S,5R,6R)-6-(acetoxymethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate→(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
2-(4-fluorophenyl)thiophene→2-bromothiophene→1-bromo-4-fluorobenzene→5-iodo-2-methylbenzoyl chloride→2-(4-fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene→(2R,3R,4S,5R)-2-(acetoxymethyl)-6-oxotetrahydro-2H-pyran-3,4,5-triyl triacetate→(3R,4S,5R,6R)-6-(acetoxymethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate→(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
1-oxo-1,3-dihydroisobenzofuran-5-carbonitrile→1-bromo-4-fluorobenzene→magnesium (5-cyano-2-(4-fluorobenzoyl)phenyl)methanolate bromide→3-chloro-N,N-dimethylpropan-1-amine→magnesium 1-(4-cyano-2-(oxidomethyl)phenyl)-4-(dimethylamino)-1-(4-fluorophenyl)butan-1-olate bromide chloride→4-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile→(R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoic acid
3-chloro-N,N-dimethylpropan-1-amine→5-iodoisobenzofuran-1(3H)-one→magnesium (2-(4-fluorobenzoyl)-5-iodophenyl)methanolate bromide→magnesium 4-(dimethylamino)-1-(4-fluorophenyl)-1-(4-iodo-2-(oxidomethyl)phenyl)butan-1-olate bromide chloride→4-(dimethylamino)-1-(4-fluorophenyl)-1-(2-(hydroxymethyl)-4-iodophenyl)butan-1-ol→(S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-(2-(hydroxymethyl)-4-iodophenyl)butan-1-ol→(S)-3-(1-(4-fluorophenyl)-5-iodo-1,3-dihydroisobenzofuran-1-yl)-N,N-dimethylpropan-1-amine→1-bromo-4-fluorobenzene
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.